Table 3(b) Univariate and multivariate analyses for cardiovascular and/or limb events (CVLE: cardiovascular or cerebrovascular death, nonfatal myocardial or cerebral infarction, transient ischemic attack, major amputation, or repeat revascularization for a limb).
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95%CI | p-value | HR | 95%CI | p-value | |
| Age (years) | 1.019 | 1.005–1.032 | 0.007 | 1.016 | 1.001–1.031 | 0.039 |
| Ankle–brachial pressure index | 0.383 | 0.245–0.599 | <0.001 | 0.452 | 0.261–0.781 | 0.004 |
| Critical limb ischemia | 1.857 | 1.316–2.621 | <0.001 | 1.347 | 0.980–1.851 | 0.066 |
| Diabetes mellitus | 1.433 | 1.109–1.853 | 0.006 | 1.278 | 0.962–1.698 | 0.091 |
| Cerebral infarction | 1.632 | 1.187–2.242 | 0.003 | 1.450 | 1.016–2.069 | 0.041 |
| Coronary heart disease | 2.175 | 1.687–2.805 | <0.001 | 2.091 | 1.575–2.776 | <0.001 |
| Urinary albumin (mg/gCr) | 1.001 | 1.000–1.001 | <0.001 | 1.001 | 1.000–1.001 | 0.007 |
| Serum albumin (g/dL) | 0.498 | 0.365–0.679 | <0.001 | 0.797 | 0.555–1.143 | 0.217 |
| eGFR (mL/min/1.73 m2) | 0.990 | 0.983–0.997 | 0.003 | 1.000 | 0.993–1.008 | 0.918 |
| C-reactive protein (mg/dL) | 1.087 | 1.002–1.179 | 0.045 | 1.052 | 0.955–1.159 | 0.306 |
| Statin | 0.479 | 0.363–0.621 | <0.001 | 0.515 | 0.386–0.687 | <0.001 |
HR: hazard ratio; CI: confidence interval; eGFR: estimated glomerular filtration rate